Free public records show Keymed Biosciences Co.Ltd in 4 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Keymed Biosciences Co.Ltd or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
29 active studies led by Keymed Biosciences Co.Ltd, of 68 in all
Source: ClinicalTrials.gov, Studies with Keymed Biosciences Co.Ltd (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
1 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Studies Keymed Biosciences Co.Ltd leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Keymed Biosciences Co.Ltd or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Keymed Biosciences Co.Ltd: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Keymed Biosciences Co.Ltd is in.
Stories on the topics Keymed Biosciences Co.Ltd works in.
Seasonal flu causes about a billion cases a year. Vitamin C and zinc can shorten colds a little, but vaccines…
Read
Collagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
Read
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
ReadSearch all reports for Keymed Biosciences Co.Ltd All companies